Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

YOU WONT BELIEVE: 2 - You Need To See This

Purdue Pharma Faces Challenges In Opioid Lawsuit Settlement

Purdue Pharma seeks new settlement after Supreme Court rejection in opioid crisis fallout.

Top News

The threat of litigation looms as Purdue Pharma returns to settlement talks

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one

The Independent UK

US supreme court decisions: the biggest cases this term and their outcomes

The court has wrapped up its term, issuing a string of blockbuster decisions with the conservative supermajority in the driver’s seat

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

US Supreme Court Rejects Opioid Settlement That Shields Sackler Family

The US Supreme Court on Thursday rejected Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation.

International Business Times

Divided Over Purdue Pharma Deal, SCOTUS Unites in Accepting a Dubious OxyContin Narrative

The majority and the dissenters agree that the drug was "central" to "the opioid crisis," even though there is little evidence to support that thesis.

Reason

Supreme Court rejects settlement with OxyContin maker Purdue Pharma over legal protections for the Sackler family that owned the company

The Supreme Court ruled 5-4 against an estimated US$6 billion Purdue Pharma bankruptcy plan on June 27, 2024, that would have shielded the Sackler family – which owned and controlled the company – from legal liability.

The Conversation

SCOTUS Reverses Purdue Pharma Opioid Settlement, Threatening Billions For Victims

The ruling dealt a blow to Purdue Pharma's bankruptcy reorganization plan, which aimed to allocate billions of dollars to victims of opioid addiction while shielding the Sackler family from future lawsuits.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

US Supreme Court rejects $6 billion OxyContin settlement shielding Sackler family

The US Supreme Court on Thursday rejected OxyContin maker Purdue Pharma's $6 billion settlement that would have shielded the Sackler family, who owned the company and earned tens of billions as it flooded the country with the highly addictive drug, from future civil lawsuits over the role they played in…

France 24

The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know

The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company

The Independent UK

Supreme Court shreds nationwide $6 billion opioid settlement plan in ruling against Sackler family

The Supreme Court said the Sackler family cannot use a Chapter 11 reorganization plan to protect themselves from civil liability

The Independent UK

US supreme court blocks Purdue Pharma’s bankruptcy settlement that would shield Sacklers from lawsuits

Controversial deal would have protected billionaire family owners from further liability over US opioid epidemic

The Guardian - US

The Supreme Court rejects a nationwide opioid settlement with OxyContin maker Purdue Pharma

The Supreme Court has rejected a nationwide settlement with OxyContin maker Purdue Pharma that would've shielded Sackler family members who own the company from civil lawsuits over the toll of opioids but also would've provided billions of dollars to combat the epidemic

The Independent UK

Supreme Court blocks Purdue Pharma bankruptcy plan - Roll Call

The 5-4 opinion will send victims of the opioid crisis back to settlement negotiations with the company and the Sackler family.

Roll Call

Supreme Court has a lot of work to do and little time to do it with a sizable case backlog

The Supreme Court has a lot of work left to do and little time to do it

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

McKinsey Under Criminal Investigation Over Alleged Role In Fueling Opioid Epidemic

McKinsey & Company is facing a criminal investigation by U.S. attorneys' offices in Massachusetts and the Western District of Virginia for its alleged role in fueling the opioid epidemic.

International Business Times

Publicis Settles Opioid Case With US States For $350 Mn

Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday.

The Guardian - US

‘I don’t see how it ends’: expert sounds alarm on new wave of US opioids crisis

Dr Art Van Zee set out in the early 2000s to tell anyone who would listen how a powerful opioid was destroying lives. Two decades later, he’s still in disbelief

Top News

McKinsey to Pay Million in Opioid Crisis Settlement

Consulting firm McKinsey agrees to pay million to settle claims related to its role in fueling the opioid addiction crisis, reimbursing insurers and he...

The Independent UK

Consulting firm McKinsey agrees to $78 million settlement with insurers over opioids

Consulting firm McKinsey and Co. has agreed to pay $78 million to settle claims from insurers and health care funds that its marketing work with Purdue Pharma helped fuel an opioid addiction crisis

WEKU

In 2023, opioid settlement funds flowed to states. Here's how it's going

Some $1.5 billion flowed to local government coffers this year, sparking debates about transparency and how to spend the money. Here are 5 takeaways from a year's worth of reporting on the issue.

The Guardian - UK

Best films of 2023 in the UK: No 9 – All the Beauty and the Bloodshed

Laura Poitras’s powerful documentary follows artist Nan Goldin on a successful crusade to publicise America’s opioids crisis

International Business Times

Divided US High Court Hears Challenge To $6bn Purdue Opioid Settlement

The US Supreme Court appeared divided on Monday as it heard a challenge to Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family that controlled the drugmaker from future litigation.

The Independent UK

The Sackler family wants protection from opioid lawsuits. Will the Supreme Court grant it?

A bankruptcy case before the Supreme Court could grant the Sackler family immunity from opioid-related civil cases Ariana Baio reports

The Independent UK

Watch Live: Supreme Court weighs legality of Purdue Pharma bankruptcy settlement

Watch live as the Supreme Court hears arguments around the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement, on 4 December 2023.

1 2 3 4 5

People

[ Brett M. ] Kavanaugh

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.